Parabolic Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 20	Mar ' 19	Mar ' 18	Mar ' 17	Mar ' 16

Sales

-

18.08

72.60

77.97

75.90

Operating profit

-6.41

-14.77

-16.04

-41.62

-306.08

Interest

0.66

3.46

8.35

9.91

107.62

Gross profit

-7.05

-17.42

-20.28

-51.53

-413.70

EPS (Rs)

-4.63

-6.57

-9.14

-17.46

-78.40

Other income

0.02

0.81

4.11

-

-

Stock adjustment

-

5.26

-0.73

27.86

270.31

Raw material

-

14.73

64.22

64.08

58.20

Power and fuel

-

-

-

-

-

Employee expenses

1.68

5.34

8.88

8.47

10.68

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

4.73

7.52

16.27

19.18

42.79

Provisions made

-

-

-

-

-

Depreciation

21.59

21.77

34.54

53.49

67.06

Taxation

-

-0.41

1.76

3.05

4.43

Net profit / loss

-28.64

-40.66

-56.58

-108.07

-485.19

Extra ordinary item

-

-1.88

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

61.89

61.89

61.89

61.89

61.89

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

384.96

379.75

Agg.of non promotoholding (%)

-

-

-

62.20

61.36

OPM (%)

-

-81.69

-22.09

-53.38

-403.27

GPM (%)

-

-92.22

-26.44

-

-

NPM (%)

-

-215.25

-73.76

-

-